MedPath

The effect of co-administration Antiemetics and Hyangsa Youkgunja-tang extract for Anorexia in cancer patients : a pilot study

Not Applicable
Recruiting
Conditions
Neoplasms
Registration Number
KCT0003716
Lead Sponsor
Comprehensive & Integrative Medicine Institute
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

1. the cancer patients who complain nausea, vomiting and anorexia even if taking antiemetics
2, NRS of anrorexia is over 4
3. life expactancy is more than 3 months.
4. their age is 20-70
5. they have no problems in languagem expression and concentration
6. those who can follow up during the trial
7. those who voluntarily decide to participate and signed the consent

Exclusion Criteria

1. those who have hypersinsitivity with hyangsayoukgunja-Tang
2. Those with genetic problems such as galactose intolerance, Lapp lactase deficiency or glucose-calactose absorption disorder
3. major mental illness, such as major depression or mental illness;
4. Those who have difficulty eating food due to stomatitis, glossitis.
5. Liver function test, kidney function test, more than twice the normal level (AST, ASL 80 IU/L, creatine 2.4 mg% or higher) or moderate liver and renal failure patients
6. Hb<8.0 or below
7. pregnancy and lactating women

Study & Design

Study Type
Interventional Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
anorexia cachexia scale
Secondary Outcome Measures
NameTimeMethod
Edmonton symptom assessment scale;Functional Assessment of Anorexia/Cachexia therapy;body mass index;patient global impression of chaneg;Blood test(total protein, albumin, total cholerterol and hormone(Ghrelin, leptine)
© Copyright 2025. All Rights Reserved by MedPath